Home / Health / Late Cancer Costs Skyrocket: Early Detection is Key
Late Cancer Costs Skyrocket: Early Detection is Key
25 Oct
Summary
- Late-stage breast cancer treatment costs Medicare beneficiaries $25,000 vs. $700 for early detection.
- Breast cancer death rates fell 44% since 1989 due to earlier diagnosis and better treatment.
- Millions of women lack mammography facilities within a 20-minute drive, exacerbating access issues.
The financial burden of late-stage breast cancer is immense, with Medicare beneficiaries facing average first-year drug costs of approximately $25,000 for advanced disease, a stark contrast to the $700 for localized cancer. Overall medical spending more than doubles after the cancer spreads.
Early detection significantly reduces mortality and costs. The breast-cancer death rate has fallen 44 percent since 1989, largely attributed to earlier diagnosis and improved treatments. However, systemic issues continue to impede timely screening and diagnosis for many women.
Access barriers persist, with nearly 8 million women aged 45 to 84 living more than a 20-minute drive from a mammography facility. Certificate-of-need laws in some states restrict competition, limiting options for patients needing scans.
Simplifying the diagnostic process is crucial. Women often face delays in scheduling follow-up appointments or obtaining necessary referrals after abnormal screenings. Streamlining these administrative hurdles and reducing insurance pre-authorization requirements for advanced imaging can expedite diagnosis.
